observational/translational study for nivolumab treatment in advanced esophageal cancer
Not Applicable
Recruiting
- Conditions
- esophageal cancer
- Registration Number
- JPRN-UMIN000043208
- Lead Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients previously received major gastrointestinal surgery (2) Patients previously treated with nivolumab. (3) Patients who are regarded as inadequate for study enrollment by investigators.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method